Reduce depression anxiety and stress
- Trial ID
- NCT06821230
- Official Title
- Enhancing Psychological Wellbeing and the Patient-caregiver Relationship Through Dyadic Mindfulness: A Randomized Controlled Trial in People With Parkinson's Disease and Their Caregivers
- Goal
- Reduce depression anxiety and stress
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- The University of Hong Kong
- Study Type
- INTERVENTIONAL
- Enrollment
- 200 participants
- Conditions
- Mindfulness, Caregivers, Movement Disorders, Neurodegenerative Disease, Dyadic Intervention, Psychosocial Health, Parkinsons Disease
- Interventions
- Dyadic mindfulness
Plain-Language Summary
Aims to boost psychological wellbeing and strengthen the patient-caregiver relationship for people with mild to moderate Parkinson's who are experiencing at least mild depression, anxiety, or stress. It offers a dyadic mindfulness program where the person with PD and their primary caregiver learn guided attention, breathing, and emotion-regulation practices together to reduce stress and low mood, improve communication and empathy, and provide coping tools that complement medications rather than replace them. Looking for Cantonese-speaking patient-caregiver pairs, with patients aged 50 to 80, Hoehn and Yahr stage I to III, and at least one DASS-21 threshold met (depression ≥10, anxiety ≥8, or stress ≥15). Excludes pairs already doing regular supervised mind-body practice more than twice weekly, those with acute psychosis, significant cognitive impairment, current participation in other trials, or major hearing/vision problems that would limit participation.
Locations
- School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dyadic mindfulness. Aims to boost psychological wellbeing and strengthen the patient-caregiver relationship for people with mild to moderate Parkinson's who are experiencing at least mild depression, anxiety, or stress. It offers a dyadic mindfulness program where the person with PD and their primary caregiver learn guided attention, breathing, and emotion-regulation practices together to reduce stress and low mood, improve communication and empathy, and provide coping tools that complement medications rather than replace them. Looking for Cantonese-speaking patient-caregiver pairs, with patients aged 50 to 80, Hoehn and Yahr stage I to III, and at least one DASS-21 threshold met (depression ≥10, anxiety ≥8, or stress ≥15). Excludes pairs already doing regular supervised mind-body practice more than twice weekly, those with acute psychosis, significant cognitive impairment, current participation in other trials, or major hearing/vision problems that would limit participation.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 5 months.